Twist Bioscience CorpTWST
Price$193.24Intrinsic value$52.5773% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $431.8M+38.0% YoYTTM through 30 Jun 2026
Net Income -$136.7MTTM through 30 Jun 2026
Free Cash Flow -$93.1MTTM through 30 Jun 2026

Margins

Current
Gross Margin51.6%
EBITDA Margin-27.7%
Operating Margin-39.7%
Net Margin-31.7%

Returns

-15.7%ROE
-10.5%ROA

Balance Sheet Health

Debt / Equity0.21x
Current Ratio2.70x
Net Debt-$171.7Mnet cash position
Cash & Equivalents$117.4M

Quality Metrics

Altman Z-Score26.20
Piotroski F-Score3 / 9
FCF Margin-21.6%
Rule of 40-15.9
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $376.6M
Diluted EPS-$2.23TTM
'20'21'22'23'24'25
FY2025: $-1.30

Dividend

No dividend

Capital Allocation

R&D Spend$71.9M
Capex Intensity9.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.